NovoCure Ltd Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2014 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
NovoCure Ltd quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2014 to Q4 2023.
  • NovoCure Ltd Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $375M, a 3.88% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $375M +$14M +3.88% Dec 31, 2023 10-K 2024-02-22
Q4 2022 $361M -$14.4M -3.82% Dec 31, 2022 10-K 2024-02-22
Q4 2021 $376M +$11.6M +3.2% Dec 31, 2021 10-K 2023-02-23
Q4 2020 $364M +$7.07M +1.98% Dec 31, 2020 10-K 2022-02-24
Q4 2019 $357M +$245M +218% Dec 31, 2019 10-K 2021-02-25
Q4 2018 $112M +$36.6M +48.2% Dec 31, 2018 10-K 2020-02-27
Q4 2017 $75.8M +$5.74M +8.2% Dec 31, 2017 10-K 2019-02-28
Q4 2016 $70.1M +$36.6M +109% Dec 31, 2016 10-K 2018-02-22
Q4 2015 $33.5M +$19.6M +140% Dec 31, 2015 10-K 2017-02-23
Q4 2014 $13.9M Dec 31, 2014 10-K 2016-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.